SCYNEXIS, Inc. - Special Call Transcript
Good morning, and welcome to the SCYNEXIS Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the call over to Irina Koffler, Investor Relations. You may begin.
Good morning, and thank you for joining us as we report positive results from the third interim analysis of our ongoing oral ibrexafungerp Phase III, open-label FURI study and our first analysis of the CARES study. Joining me today from SCYNEXIS are Dr. Marco Taglietti, President and Chief Executive Officer; and Dr. David Angulo, Chief Medical Officer. And joining them today is Dr. Andrej Spec, Assistant Professor, Infectious Disease; Associate Director of the Infectious Disease Clinical Research Unit; and Director, Invasive Mycoses Clinic at Washington University School of Medicine in St. Louis.
During this call, please note we will be making forward-looking statements. These statements are subject to factors, risks and uncertainties, including those that are detailed in today's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
